Physical activity, exercise benefit patients with lung cancer, survivors
the ONA take:
According to a new study published in the Journal of Thoracic Oncology, researchers at The Medical University of South Carolina in Charleston, South Carolina, have found that physical activity should be considered as a therapeutic option of patients with lung cancer as exercise and physical activity have been shown to reduce symptoms, improve quality of life, increase exercise tolerance, and decrease length of hospitalization and post-surgery complications for lung cancer.
The authors found that most patients with lung cancer want advice about physical activity from a cancer center physician before cancer therapy and exercise guidance may improve compliance with the use of a dedicated program. Another important finding was that exercise and physical activity are safe for those with lung cancer.
In addition, both patients with lung cancer and lung cancer survivors experienced the same benefits of increased activity, particularly improved symptoms and quality of life.
The authors conclude that health care professionals should consider physical activity early and encourage physical activity in patients any stage of lung cancer and lung cancer survivors.
Physical activity have been shown to reduce lung cancer symptoms, improve quality of life.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|